[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$actu
Actuate Therapeutics stock plunges after public offering announcement. Analysts initiated coverage with a buy rating, but the stock price is still down from the offering news.
About $actu
Actuate Therapeutics, Inc. (ACTU) is a biotechnology company.
Engagements: XX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXXXX
1 Week: XXX -XX%
1 Month: XXXXXX +20%
1-Year High: XXXXXX on 2025-06-02
1-Year Low: X on 2025-10-09
| Social Network | X |
|---|---|
| Engagements | XX |
Mentions: X #
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: XX
1-Year High: XXX on 2025-06-27
1-Year Low: X on 2025-10-08
| Social Network | X |
|---|---|
| Mentions | X |
Creators: X #
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $actu in the last XX hours which is down XX% from X in the previous XX hours
Daily Average: XX
1-Year High: XXX on 2025-06-27
1-Year Low: X on 2025-09-20
Top assets mentioned In the posts about $actu in the last XX hours
Avidity Biosciences, Inc. Common Stock (RNA)
Top topics mentioned In the posts about $actu in the last XX hours
primary market, $cocp, $rna, university of, stocks healthcare, pricing, $blte, $dnth
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"🧬 Biotech Stock News 09/12 Brought to you by Barb On the rise 📈 $COCP XX% $RNA X% $BLTE X% Under pressure 📉 $DNTH -X% $ACTU -X% $DTIL -X% Catch the full breakdown in the latest video"
X Link @BiopharmIQ 2025-09-12T16:50Z 27.2K followers, 2744 engagements
"📌 Biotech Stock News 9/12 @ Open $COCP XX% CDI-988 for Norovirus Presented @ ICC'25 $RNA X% Pricing of Upsized Public Offering $BLTE X% Tinlarebant Ph3 Trial Completion $UTHR X% Clinical Data at European Congress $OSTX -X% Last Patient Enrolled in OST-504 Trial $DNTH -X% Closing of $288M Offering $ACTU -X% Closing of $17.25M Offering $DTIL -X% Data from Ph1 PBGENE-HBV Trial See the image and comments for more details"
X Link @BiopharmIQ 2025-09-12T14:57Z 27.2K followers, 7825 engagements
"Top Market Movers: Negative News Full Access: $ACTU 6.97$ -XXXXX% September XX 2025 Actuate Therapeutics Announces Proposed Public Offering of Common Stock"
X Link @Biopharma_Watch 2025-09-10T15:45Z 1115 followers, XXX engagements
"News; $ACTU Actuate Therapeutics To Collaborate with Incyte Corporation and the University of Pittsburgh on Clinical Trial of Elraglusib in Combination with Retifanlimab and mFOLFIRINOX in Patients with Advanced Pancreatic Cancer Follow for daily #StockNews @grok please provide the finance card for $ACTU"
X Link @marketwirenews 2025-08-06T20:10Z 61.9K followers, XXX engagements